Order Article Reprints

Isla D, Sánchez A, Casal J, Cobo M, Majem M, Reguart N, Zugazagoitia J, Bernabé R. PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement. Journal of Clinical Medicine. 2023; 12(15):5063. https://doi.org/10.3390/jcm12155063

Isla, Dolores, Alfredo Sánchez, Joaquín Casal, Manuel Cobo, Margarita Majem, Noemi Reguart, Jon Zugazagoitia, and Reyes Bernabé. 2023. "PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement" Journal of Clinical Medicine 12, no. 15: 5063. https://doi.org/10.3390/jcm12155063

Isla, D., Sánchez, A., Casal, J., Cobo, M., Majem, M., Reguart, N., Zugazagoitia, J., & Bernabé, R. (2023). PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement. Journal of Clinical Medicine, 12(15), 5063. https://doi.org/10.3390/jcm12155063